Abstract
In patients with sludge or severe spontaneous echo contrast (SEC) in the left atrial appendage (LAA), cases with isoproterenol loading transesophageal echocardiography (ISP-TEE) have been reported to identify the presence of thrombus in the LAA. This study aimed to assess the validity and hemodynamic changes of ISP-TEE in the LAA. We prospectively enrolled patients with atrial fibrillation (AF) who underwent ISP-TEE. The degree of sludge/SEC was categorized as being either absent (grade 0), mild SEC (grade 1), moderate SEC (grade 2), severe SEC or sludge (grade 3). The hemodynamic evaluation was performed by measuring LAA flow velocity, LAA tissue Doppler imaging (LAA-TDI) velocity, and pulmonary vein systolic forward flow velocity (PVS). In total, 35 patients (mean age 71 ± 7 years; 71% male) underwent ISP-TEE. Among 35 patients, 30 patients had grade 3 or 2 SEC, 5 patients had grade 1 SEC. After ISP loading, 23 patients (66% of all patients) showed improved sludge/SEC and one patient was diagnosed with thrombus in the LAA. There were 25 patients with grade 1 SEC, or no SEC (classified as Group1), 10 patients had residual sludge or grade 2 to 3 SEC (classified as Group2) after ISP administration. LAA flow, LAA-TDI, and PVS velocities were significantly higher in group 1 than in group 2 after ISP administration. There was no complication during the examination and after 24 h and 3 months. ISP infusion may be a potential tool to recognize LAA thrombus under the sludge/SEC during TEE in AF.
Similar content being viewed by others
Data availability
Data are available upon reasonable request.
References
Spence D (2009) Mechanisms of thrombogenesis in atrial fibrillation. The Lancet 373:1006
Beigel R, Wunderlich NC, Ho SY, Arsanjani R, Siegel RJ (2014) The left atrial appendage: anatomy, function, and noninvasive evaluation. JACC: Cardiovasc imaging 7:1251–1265
Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C et al (2021) 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J 42:373–498
Calkins H, Hindricks G, Cappato R, Kim Y-H, Saad EB, Aguinaga L et al (2018) 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Ep Europace 20:e1–e160
Meier B, Blaauw Y, Khattab AA, Lewalter T, Sievert H, Tondo C et al (2014) EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion. Europace 16:1397
Lowe BS, Kusunose K, Motoki H, Varr B, Shrestha K, Whitman C et al (2014) Prognostic significance of left atrial appendage “sludge” in patients with atrial fibrillation: a new transesophageal echocardiographic thromboembolic risk factor. J Am Soc Echocardiogr 27:1176–1183
Pandey AC, Smith MR, Olson N, Price MJ, Gibson DN (2019) When smoke does not always mean there is fire: using isoproterenol for better visualization of the left atrial appendage prior to transcatheter closure. JACC: Clin Electrophysiol 5:136–137
Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L et al (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J-Cardiovasc Imaging 16:233–271
Nagueh SF, Smiseth OA, Appleton CP, Byrd BF, Dokainish H, Edvardsen T et al (2016) Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur J Echocardiogr 17:1321–1360
Fatkin D, Kelly RP, Feneley MP (1994) Relations between left atrial appendage blood flow velocity, spontaneous echocardiographic contrast and thromboembolic risk in vivo. J Am Coll Cardiol 23:961–969
Johri AM, Chitty DW, Matangi M, Malik P, Mousavi P, Day A et al (2013) Can carotid bulb plaque assessment rule out significant coronary artery disease? A comparison of plaque quantification by two-and three-dimensional ultrasound. J Am Soc Echocardiogr 26:86–95
Di Biase L, Santangeli P, Anselmino M, Mohanty P, Salvetti I, Gili S et al (2012) Does the left atrial appendage morphology correlate with the risk of stroke in patients with atrial fibrillation? Results from a multicenter study. J Am Coll Cardiol 60:531–538
Maltagliati A, Galli CA, Tamborini G, Calligaris A, Doria E, Salehi R et al (2006) Usefulness of transoesophageal echocardiography before cardioversion in patients with atrial fibrillation and different anticoagulant regimens. Heart 92:933–938
Hajjiri M, Bernstein S, Saric M, Benenstein R, Aizer A, Dym G et al (2014) Atrial fibrillation ablation in patients with known sludge in the left atrial appendage. J Interv Card Electrophysiol 40:147–151
Squara F, Bres M, Scarlatti D, Moceri P, Ferrari E (2020) Clinical outcomes after AF cardioversion in patients presenting left atrial sludge in trans-esophageal echocardiography. J Interv Card Electrophysiol 57:149–156
Udelson J, Cannon R 3rd, Bacharach S, Rumble T, Bonow R (1989) Beta-adrenergic stimulation with isoproterenol enhances left ventricular diastolic performance in hypertrophic cardiomyopathy despite potentiation of myocardial ischemia. Comp rapid atr pacing Circ 79:371–382
Date T, Takahashi A, Iesaka Y, Miyazaki H, Yamane T, Noma K et al (2002) Effect of low-dose isoproterenol infusion on left atrial appendage function soon after cardioversion of chronic atrial tachyarrhythmias. Int J Cardiol 84:59–67
Manning WJ, Weintraub RM, Waksmonski CA, Haering JM, Rooney PS, Maslow AD et al (1995) Accuracy of transesophageal echocardiography for identifying left atrial thrombi: a prospective, intraoperative study. Ann Intern Med 123:817–822
Ebelt H, Offhaus A, Wiora M, Roehl P, Schwenzky A, Weida A et al (2019) Impact of ultrasound contrast agent on the detection of thrombi during transoesophageal echocardiography. Open Heart 6:e001024
Funding
This work was supported by Takeda Science Foundation (to K. Kusunose). The funding source had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Author information
Authors and Affiliations
Contributions
Design of the work: TT, KK, and SH. Conduct of the work and data acquisition: TT, SH, NY, SM, YH, SN, YS, TI, KY, SY, HY, TS, and TW. Data analysis and interpretation: TT and KK. Drafting the work: TT, KK, SH, and RZ. Reviewing the work and providing input: all authors. Final approval: all authors.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Conflict of interest
The authors have not disclosed any competing interests.
Disclosures
None.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Takahashi, T., Kusunose, K., Hayashi, S. et al. Isoproterenol loading transesophageal echocardiography in atrial fibrillation. Int J Cardiovasc Imaging 39, 511–518 (2023). https://doi.org/10.1007/s10554-022-02749-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10554-022-02749-y